About Quintian Pharma
Quintian Pharma is a company based in Malta (United States) founded in 2015 was acquired by PQE Group in July 2022. Quintian Pharma offers products and services including EU GMP Certification, EU Batch Testing and Release, Pharmacovigilance, and EU-CTD Registration. Quintian Pharma operates in a competitive market with competitors including Indegene, IntegriChain, Clinigen, Zuellig Pharma and Science Group, among others.
- Headquarter Malta, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Quintian Pharma
Quintian Pharma offers a comprehensive portfolio of products and services, including EU GMP Certification, EU Batch Testing and Release, Pharmacovigilance, and EU-CTD Registration.
Service for certifying pharmaceutical manufacturing sites to EU standards
Analysis and certification of pharmaceutical batches for market release
Post-marketing surveillance of pharmaceutical products for safety
Compilation and submission of regulatory dossiers for EU approval
Funding Insights of Quintian Pharma
Detailed funding history for Quintian Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Quintian Pharma
Quintian Pharma has secured backing from 1 investor. Prominent investors backing the company include PQE Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Offers regulatory affairs, auditing, and compliance services to businesses.
|
Locked | Locked | Locked |
Investor details for Quintian Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Quintian Pharma
Investment portfolio details for Quintian Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Quintian Pharma
Detailed financials for Quintian Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Quintian Pharma Comparisons
Peer comparison for Quintian Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Quintian Pharma
Quintian Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, IntegriChain, Clinigen, Zuellig Pharma and Science Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Suite solutions are provided for payers and healthcare providers.
|
|
| Locked | Locked | Locked |
Inventory, order and customer relationship management solution for life science suppliers.
|
|
| Locked | Locked | Locked |
Specialty medicines are supplied via clinical trials and access programs.
|
|
| Locked | Locked | Locked |
Healthcare access in Asia is enhanced by Zuellig Pharma.
|
|
| Locked | Locked | Locked |
Technology-based consultancy and product development services are provided.
|
|
| Locked | Locked | Locked |
Strategic consulting services are provided to life sciences companies.
|
Detailed competitors of Quintian Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Quintian Pharma
Complete news archive for Quintian Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Quintian Pharma
Quintian Pharma was founded in 2015.
Quintian Pharma is headquartered in Malta, United States. It is registered at Malta, Ohio, United States.
Quintian Pharma was established in 2015 as a provider of services in the pharmaceutical sector. Operations are focused on quality assurance, pharmacovigilance, and regulatory affairs, supporting compliance and safety in drug development. The company maintains locations in Malta and the United States, serving clients across international markets with specialized consulting and monitoring solutions.
Quintian Pharma's top competitors include Indegene, Zuellig Pharma and IntegriChain.
Quintian Pharma offers EU GMP Certification, EU Batch Testing and Release, Pharmacovigilance, and EU-CTD Registration.
Quintian Pharma has 1 investor. Key investors include PQE Group.